William Stoutt, DO
Cardiovascular Disease · Corvallis, ORNPI 1750777397
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.6%), food and beverage and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 49.8% of the total. Reporting peaked in 2024 at $4,758 and has fallen 93.1% since, to $328 in 2025.
Across 56 payments — averaging $129.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- GE HealthCare$2K
- Abiomed$954
- Medtronic$409
- Boston Scientific$349
- Biotronik Inc.$136
- plus $246 from 6 others
What the payments were for
- Grants$3495%
- Travel & lodging$3,67451%
- Food & beverage$2,95941%
- Education$2804%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $3,620 |
| GE HealthCare | 3 | $1,547 |
| Abiomed | 15 | $954 |
| Medtronic | 3 | $409 |
| Boston Scientific | 1 | $349 |
| Biotronik Inc. | 1 | $136 |
| Philips North America LLC | 1 | $124 |
| Teleflex LLC | 1 | $36 |
| Shockwave Medical, Inc | 1 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Novartis | 1 | $16 |
| Terumo Medical Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$2,310
- ALLIA$1,385
- Impella$449
- GENERAL ATHERECTOMY$349
- Resolute$280
- Assurity Pacemaker$152
- Orsiro Mission$136
- (6361) Core Mobile$124
- XIENCE SIERRA$119
- ATTAIN COMMAND + SUREVALVE$109
- ALLURE QUADRA$109
- ALLURE$106
How this compares
$7,262 in reported general payments places this provider in the 80th percentile of 198 cardiovascular disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $28,841 |
| Atorvastatin Calcium | 158 | $2,036 |
| Metoprolol Succinate | 127 | $1,807 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 84 | $1,113 |
| Rosuvastatin Calcium | 64 | $1,058 |
| Ranolazine ErRanolazine | 27 | $969 |
| ClopidogrelClopidogrel Bisulfate | 52 | $798 |
| Torsemide | 28 | $642 |
| Potassium Chloride | 21 | $508 |
| Ezetimibe | 18 | $507 |
| Amlodipine Besylate | 65 | $352 |
| Losartan Potassium | 33 | $246 |
| Furosemide | 37 | $197 |
| Nitroglycerin | 16 | $160 |
| Carvedilol | 29 | $158 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Corvallis
- Ashwat DhillonCorvallis$156K
- Jose Lozano GarciaCorvallis$31K
- Edward ToggartCorvallis$3K
- Firas ZahrPortland$810K
- Kathy GreweHood River$376K
- Scott ChadderdonPortland$282K
- Ahmad MasriPortland$227K
- Stephen HeitnerPortland$105K
- Ian RiddockBend$81K
- Abhushan PoudyalPortland$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.